Quick Answer
Celularity Inc reported Earnings Per Share Diluted of $2.64 (loss) per share for the year ending 2024.
- Celularity Inc showed an increase of +76.0% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Celularity Inc's annual report (Form 10-K), filed with the SEC on May 8, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $2.52 (loss) per share | Q2 2021: $2.69 (loss) per share | Q3 2021: $0.40 per share | Q1 2022: $0.48 (loss) per share | Q2 2022: $0.32 per share | Q3 2022: $0.03 per share | Q1 2023: $4.12 (loss) per share | Q2 2023: $2.72 (loss) per share | Q3 2023: $4.98 (loss) per share | Q1 2024: $1.03 (loss) per share | Q2 2024: $0.30 (loss) per share | Q3 2024: $0.73 (loss) per share | Q1 2025: $0.84 (loss) per share | Q2 2025: $1.02 (loss) per share | Q3 2025: $0.88 (loss) per share.
- Over the full 4 years of available data (2021 to 2024), Celularity Inc's Earnings Per Share Diluted has declined by 77.2%.
- Historical annual values: Fiscal year 2024: $2.64 (loss) per share | Fiscal year 2023: $11.02 (loss) per share | Fiscal year 2022: $0.95 per share | Fiscal year 2021: $1.49 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: